FDA approves tuberculosis drug.
D
D
Josefson
D000995:Antitubercular Agents / Q000627:therapeutic use*; D006801:Humans; D007880:Legislation, Drug; D012293:Rifampin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration
D000995:Antitubercular Agents; D012293:Rifampin; C018421:rifapentine